ESM3 represents a step towards using AI as a tool for engineering proteins from first principles, akin to structures, machines, and microchips.
Characterizing and creating proteins through AI could unlock new drugs and therapeutics while reducing costs in the current protein design process.
ESM3, trained on a data set of 2.78 billion proteins, can reason over sequences, structures, and functions to generate new proteins.
Collection
[
|
...
]